RT Conference Proceedings
T1 SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+)/PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial
A1 Ciruelos, E. M.
A1 Ponce, J.
A1 Pernas Simon, S.
A1 Cortes, J.
A1 Cantos, B.
A1 Garate, E.
A1 Vega Alonso, E.
A1 Mele Olive, M.
A1 Martinez De Duenas, E.
A1 Montano Perianez, A.
A1 Martinez, N.
A1 Perello Martorell, A.
A1 Bermejo De las Heras, B.
A1 Arqueros Nunez, C.
A1 Fernandez, I.
A1 De la Haba Rodriguez, J.
A1 Oliveira, M.
A1 Gonzalez, X.
A1 Villagrasa Gonzalez, P.
A1 Prat, A.
PB Elsevier
SN 0923-7534
YR 2022
FD 2022-05-05
LK http://hdl.handle.net/10668/21908
UL http://hdl.handle.net/10668/21908
LA en
DS RISalud
RD Apr 7, 2025